114 results
Page 3 of 6
8-K
lvg5po
17 Jun 21
Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease
7:35am
8-K
EX-99.1
nstr9w4lvb
13 May 21
Synlogic Reports First Quarter Financial Results and Provides Business Update
6:46am
8-K
pxaxx1p6
5 May 21
Entry into a Material Definitive Agreement
4:06pm
424B5
951iv2nks
19 Apr 21
Prospectus supplement for primary offering
4:06pm
8-K
EX-1.1
sh30 2bno3y
16 Apr 21
Synlogic Announces Proposed Public Offering of Common Stock
8:35am
424B5
aj40rrr90v
15 Apr 21
Prospectus supplement for primary offering
4:21pm
8-K
EX-99.1
d5i330y
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.2
qin994j
5 Nov 20
Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria
6:31am
8-K
EX-99.1
ha3rweypok7j1a phr
6 Aug 20
Synlogic Reports Second Quarter 2020 Financial Results and Provides Business Update
7:00am
8-K
EX-99.1
pbqg f53b4hjd
8 May 20
Synlogic Reports First Quarter 2020 Financial Results and Provides Business Update
7:15am
DEFA14A
e7226zna
17 Apr 20
Additional proxy soliciting materials
4:10pm
8-K
EX-99.1
vz98wleuk6oe8eol
12 Mar 20
Synlogic Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:53pm